Production (Stage)
Exagen Inc.
XGN
$6.60
$0.579.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.50M | 13.66M | 12.51M | 15.06M | 14.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.50M | 13.66M | 12.51M | 15.06M | 14.42M |
| Cost of Revenue | 6.38M | 5.18M | 5.53M | 6.01M | 5.82M |
| Gross Profit | 9.12M | 8.48M | 6.98M | 9.06M | 8.60M |
| SG&A Expenses | 11.20M | 10.20M | 10.16M | 10.46M | 10.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.86M | 17.04M | 17.17M | 17.65M | 17.42M |
| Operating Income | -3.37M | -3.38M | -4.66M | -2.59M | -3.00M |
| Income Before Tax | -3.75M | -3.75M | -5.03M | -2.97M | -3.36M |
| Income Tax Expenses | -- | 12.00K | -- | -- | -- |
| Earnings from Continuing Operations | -3.75M | -3.76M | -5.03M | -2.97M | -3.36M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.75M | -3.76M | -5.03M | -2.97M | -3.36M |
| EBIT | -3.37M | -3.38M | -4.66M | -2.59M | -3.00M |
| EBITDA | -2.93M | -2.97M | -4.24M | -2.16M | -2.55M |
| EPS Basic | -0.20 | -0.20 | -0.28 | -0.16 | -0.19 |
| Normalized Basic EPS | -0.13 | -0.13 | -0.17 | -0.10 | -0.12 |
| EPS Diluted | -0.20 | -0.20 | -0.28 | -0.16 | -0.19 |
| Normalized Diluted EPS | -0.13 | -0.13 | -0.17 | -0.10 | -0.12 |
| Average Basic Shares Outstanding | 18.56M | 18.43M | 18.25M | 18.18M | 17.94M |
| Average Diluted Shares Outstanding | 18.56M | 18.43M | 18.25M | 18.18M | 17.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |